Topics

Xencor to Host First Quarter 2019 Financial Results Webcast and Conference Call on May 9, 2019

16:01 EDT 2 May 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer, autoimmune diseases, asthma and allergic diseases, today announced that it wil...

Other Sources for this Article

Charles Liles
626-737-8118
cliles@xencor.com

Media Contact
Jason I. Spark
Canale Communications
619-849-6005
jason@canalecomm.com

NEXT ARTICLE

More From BioPortfolio on "Xencor to Host First Quarter 2019 Financial Results Webcast and Conference Call on May 9, 2019"

Quick Search

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...